Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences profile

Associate Professor David Reith

PositionClinical Pharmacology Convenor
DepartmentDean's Department (DSM)
QualificationsMB BS MMedSc PhD DCH DipRACOG FRACP
Research summaryClinical Pharmacology
TeachingClinical pharmacology and therapeutics
Memberships
  • Chair, Medicines Adverse Reaction Committee, Medsafe
  • Chair, Editorial Advisory Board for the New Zealand Formulary

Research

  • Pharmacokinetics and pharmacodynamics using population pharmacokinetic modelling
  • Pharmacoepidemiology and drug safety
  • Medicines use in paediatric populations
  • Paediatric clinical pharmacology

Publications

Salis, E. R., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2017). Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates. Archives of Disease in Childhood: Fetal & Neonatal Edition, 102(2), F162-F166. doi: 10.1136/archdischild-2015-309174

Constance, J. E., Reith, D., Ward, R. M., Balch, A., Stockmann, C., Korgenski, E. K., … Sherwin, C. M. T. (2017). Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. Journal of Perinatology. Advance online publication. doi: 10.1038/jp.2017.80

Richards, N., Reith, D., Stitely, M., & Smith, A. (2017). Are doses of lamotrigine or levetiracetam adjusted during pregnancy? Epilepsia Open. Advance online publication. doi: 10.1002/epi4.12086

Tomlin, A. M., Reith, D. M., Woods, D. J., Lloyd, H. S., Smith, A., Fountain, J. S., & Tilyard, M. W. (2017). A pharmacoepidemiology database system for monitoring risk due to the use of medicines by New Zealand primary care patients. Drug Safety. Advance online publication. doi: 10.1007/s40264-017-0579-1

Salis, E. R., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2017). Hyperglycaemic preterm neonates exhibit insulin resistance and low insulin production. BMJ Paediatrics Open, 1(1), e000160. doi: 10.1136/ bmjpo-2017-000160

Chapter in Book - Research

Reith, D. (2011). Paediatric toxicology. In A. C. Moffatt, M. D. Osselton, B. Widdop & J. Watts (Eds.), Clarke's analysis of drugs and poisons (Vol. 1). (4th ed.) (pp. 429-444). London: Pharmaceutical Press.

^ Top of page

Journal - Research Article

Salis, E. R., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2017). Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates. Archives of Disease in Childhood: Fetal & Neonatal Edition, 102(2), F162-F166. doi: 10.1136/archdischild-2015-309174

Salis, E. R., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2017). Hyperglycaemic preterm neonates exhibit insulin resistance and low insulin production. BMJ Paediatrics Open, 1(1), e000160. doi: 10.1136/ bmjpo-2017-000160

Tomlin, A. M., Reith, D. M., Woods, D. J., Lloyd, H. S., Smith, A., Fountain, J. S., & Tilyard, M. W. (2017). A pharmacoepidemiology database system for monitoring risk due to the use of medicines by New Zealand primary care patients. Drug Safety. Advance online publication. doi: 10.1007/s40264-017-0579-1

Richards, N., Reith, D., Stitely, M., & Smith, A. (2017). Are doses of lamotrigine or levetiracetam adjusted during pregnancy? Epilepsia Open. Advance online publication. doi: 10.1002/epi4.12086

Constance, J. E., Reith, D., Ward, R. M., Balch, A., Stockmann, C., Korgenski, E. K., … Sherwin, C. M. T. (2017). Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. Journal of Perinatology. Advance online publication. doi: 10.1038/jp.2017.80

Salis, E. R., Reith, D. M., Broadbent, R. S., & Medlicott, N. J. (2016). Haematocrit influences insulin concentration measurements in dried blood spots. Journal of Maternal-Fetal & Neonatal Medicine, 29(19), 3208-3211. doi: 10.3109/14767058.2015.1119116

Chae, M., Taylor, B. J., Lawrence, J., Healey, D., Reith, D. M., Gray, A., & Wheeler, B. J. (2016). Family CHAOS is associated with glycaemic control in children and adolescents with type 1 diabetes mellitus. Acta Diabetologica, 53(1), 49-55. doi: 10.1007/s00592-015-0736-x

Linakis, M. W., Roberts, J. K., Lala, A. C., Spigarelli, M. G., Medlicott, N. J., Reith, D. M., … Sherwin, C. M. T. (2016). Challenges associated with route of administration in neonatal drug delivery. Clinical Pharmacokinetics, 55(2), 185-196. doi: 10.1007/s40262-015-0313-z

Wheeler, B. J., Lawrence, J., Chae, M., Paterson, H., Gray, A. R., Healey, D., Reith, D. M., & Taylor, B. J. (2016). Intuitive eating is associated with glycaemic control in adolescents with type I diabetes mellitus. Appetite, 96, 160-165. doi: 10.1016/j.appet.2015.09.016

Salis, E. R., Soelbeck, M. K., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2016). Effect of gestational age and blood glucose on C-peptide excretion rate and clearance in neonates. Journal of Paediatrics & Child Health, 52(1), 60-66. doi: 10.1111/jpc.12977

Bernhardt, H., Barker, D., Reith, D. M., Broadbent, R. S., Jackson, P. M., & Wheeler, B. J. (2015). Declining newborn intramuscular vitamin K prophylaxis predicts subsequent immunisation refusal: A retrospective cohort study. Journal of Paediatrics & Child Health, 51(9), 889-894. doi: 10.1111/jpc.12887

Burke, M., Bernhardt, H., Reith, D. M., Barker, D., Broadbent, R. S., & Wheeler, B. J. (2015). Perinatal influences on the uptake of newborn vitamin K prophylaxis: A retrospective cohort study. Australian & New Zealand Journal of Public Health, 39(6), 573-576. doi: 10.1111/1753-6405.12399

Owens, K. H., Medlicott, N. J., Zacharias, M., Whyte, I. M., Buckley, N. A., & Reith, D. M. (2015). Population pharmacokinetic-pharmacodynamic modelling to describe the effects of paracetamol and N-acetylcysteine on the international normalized ratio. Clinical & Experimental Pharmacology & Physiology, 42(1), 102-108. doi: 10.1111/1440-1681.12327

Lucas, C., Edmonds, L., LeRoy, J., & Reith, D. (2014). Career decisions: Factors that influence the Māori doctor. Internal Medicine Journal, 44(6), 562-567. doi: 10.1111/imj.12439

Owens, K. H., Murphy, P. G. M., Medlicott, N. J., Kennedy, J., Zacharias, M., Curran, N., Sreebhavan, S., Thompson-Fawcett, M., & Reith, D. M. (2014). Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients. Journal of Pharmacokinetics & Pharmacodynamics, 41(3), 211-221. doi: 10.1007/s10928-014-9358-0

Chae, M., Reith, D. M., Tomlinson, P., Rayns, J., & Wheeler, B. J. (2014). Accuracy of verbal self-reported blood glucose in teenagers with type I diabetes at diabetes ski camp. Journal of Diabetes & Metabolic Disorders, 13, 14. doi: 10.1186/2251-6581-13-14

Luke, S., Fountain, J. S., Reith, D. M., Braitberg, G., & Cruickshank, J. (2014). Use of poisons information resources and satisfaction with electronic products by Victorian emergency department staff. Emergency Medicine Australasia, 26(5), 494-499. doi: 10.1111/1742-6723.12283

Wheeler, B. J., Heels, K., Donaghue, K. C., Reith, D. M., & Ambler, G. R. (2014). Insulin pump–associated adverse events in children and adolescents: A prospective study. Diabetes Technology & Therapeutics, 16(9), 558-562. doi: 10.1089/dia.2013.0388

Fountain, J. S., Hawwari, H., Kerr, K., Holt, A., & Reith, D. (2014). Awareness, acceptability and application of paracetamol overdose management guidelines in a New Zealand emergency department. New Zealand Medical Journal, 127(1402). Retrieved from http://www.nzma.org.nz/journal

Fountain, J. S., Reith, D. M., & Holt, A. (2014). The utilization of poisons information resources in Australasia. International Journal of Medical Informatics, 83(2), 106-112. doi: 10.1016/j.ijmedinf.2013.10.012

Sherwin, C. M. T., Medlicott, N. J., Reith, D. M., & Broadbent, R. S. (2014). Intravenous drug delivery in neonates: Lessons learnt. Archives of Disease in Childhood, 99, 590-594. doi: 10.1136/archdischild-2013-304887

Medlicott, N. J., Reith, D. M., McCaffrey, F., Krittaphol, W., & Broadbent, R. S. (2013). Delayed delivery of intravenous gentamicin in neonates: Impact of infusion variables. Journal of Pharmacy & Pharmacology, 65(3), 370-378. doi: 10.1111/jphp.12000

Wheeler, B., Broadbent, R., & Reith, D. (2012). Premedication for neonatal intubation in Australia and New Zealand: A survey of current practice. Journal of Paediatrics & Child Health, 48(11), 997-1000. doi: 10.1111/j.1440-1754.2012.02589.x

Tomlin, A., Reith, D., Dovey, S., & Tilyard, M. (2012). Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records. Drug Safety, 35(9), 733-743. doi: 10.2165/11631970-000000000-00000

Ragupathy, R., Aaltonen, K., Tordoff, J., Norris, P., & Reith, D. (2012). A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand. Pharmacoeconomics, 30(11), 1051-1065. doi: 10.2165/11595270-000000000-00000

Owens, K. H., Medlicott, N. J., Zacharias, M., Chary, S., Thompson-Fawcett, M., & Reith, D. M. (2012). The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery. Therapeutic Drug Monitoring, 34(6), 713-721. doi: 10.1097/FTD.0b013e31826a70ea

Ragupathy, R., Tordoff, J., Norris, P., & Reith, D. (2012). Key informants' perceptions of how PHARMAC operates in New Zealand. International Journal of Technology Assessment in Health Care, 28(4), 367-373. doi: 10.1017/s0266462312000566

Aaltonen, K., Ragupathy, R., Tordoff, J., Reith, D., & Norris, P. (2010). The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand. Value in Health, 13(1), 148-156. doi: 10.1111/j.1524-4733.2009.00598.x

Wright, D. F. B., Al-Sallami, H. S., Jackson, P. M., & Reith, D. M. (2010). Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths). British Journal of Clinical Pharmacology, 70(5), 769-772. doi: 10.1111/j.1365-2125.2010.03749.x

Ragupathy, R., Tordoff, J., Norris, P., & Reith, D. (2010). Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007. Pharmacy World & Science, 32, 386-393. doi: 10.1007/s11096-010-9383-z

Kunac, D. L., Kennedy, J., Austin, N. C., & Reith, D. M. (2010). Risk factors for adverse drug events and medication errors in paediatric inpatients: Analysis by admission characteristics. Journal of Pharmacy Practice & Research, 40(4), 290-293.

Kunac, D. L., Kennedy, J., Austin, N., & Reith, D. (2009). Incidence, preventability, and impact of adverse drug events (ADEs) and potential ADEs in hospitalized children in New Zealand: A prospective observational cohort study. Pediatric Drugs, 11(2), 153-160. doi: 10.2165/00148581-200911020-00005

Reith, D., Medlicott, N. J., Kumara De Silva, R., Yang, L., Hickling, J., & Zacharias, M. (2009). Simultaneous modelling of the Michaelis-Menten kinetics of paracetamol sulphation and glucuronidation. Clinical & Experimental Pharmacology & Physiology, 36(1), 35-42. doi: 10.1111/j.1440-1681.2008.05029.x

Sherwin, C. M. T., Kostan, E., Broadbent, R. S., Medlicott, N. J., & Reith, D. M. (2009). Evaluation of the effect of intravenous volume expanders upon the volume of distribution of gentamicin in septic neonates. Biopharmaceutics & Drug Disposition, 30(5), 276-280. doi: 10.1002/bdd.666

Young, L., Lawes, F., Tordoff, J., Norris, P., & Reith, D. (2009). Access to prescribing information for paediatric medicines in the USA: Post-modernization. British Journal of Clinical Pharmacology, 67(3), 341-346. doi: 10.1111/j.1365-2125.2008.03356.x

Sherwin, C. M. T., McCaffrey, F., Broadbent, R. S., Reith, D. M., & Medlicott, N. J. (2009). Discrepancies between predicted and observed rates of intravenous gentamicin delivery for neonates. Journal of Pharmacy & Pharmacology, 61(4), 465-471. doi: 10.1211/jpp/61.04.0008

Sherwin, C., Broadbent, R., Young, S., Worth, J., McCaffrey, F., Medlicott, N. J., & Reith, D. (2008). Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. American Journal of Perinatology, 25, 629-636. doi: 10.1055/s-0028-1090585

Tordoff, J., Norris, P., Ragupathy, R., & Reith, D. (2008). Are New Zealand children still therapeutic orphans? Childrenz Issues, 12(1), 12-15.

Sherwin, C. M. T., Broadbent, R. S., Medlicott, N. J., & Reith, D. M. (2008). Individualising netilmicin dosing in neonates. European Journal of Clinical Pharmacology, 64, 1201-1208. doi: 10.1007/s00228-008-0536-0

Kunac, D. L., & Reith, D. M. (2008). Preventable medication-related events in hospitalised children in New Zealand. New Zealand Medical Journal, 121(1272), 17-32. Retrieved from http://journal.nzma.org.nz/journal/121-1272/3012/content.pdf

Tordoff, J. M., Norris, P. T., & Reith, D. M. (2008). ″Price management″ and its impact on hospital pharmaceutical expenditure and the availability of medicines in New Zealand hospitals. Value in Health, 11(7), 1214-1226. doi: 10.1111/j.1524-4733.2008.00353.x

Reith, D. M., & Edmonds, L. (2007). Assessing the role of drugs in suicidal ideation and suicidality. CNS Drugs, 21(6), 463-472.

Zacharias, M., De Silva, R. K., Hickling, J., Medlicott, N. J., & Reith, D. M. (2007). Comparative safety and efficacy of two high dose regimens of oral paracetamol in healthy adults undergoing third molar surgery under local anaesthesia. Anaesthesia & Intensive Care, 35(4), 544-549.

Balakrishnan, K., Tordoff, J., Norris, P., & Reith, D. (2007). Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002. British Journal of Clinical Pharmacology, 63(1), 85-91.

Tordoff, J. M., Murphy, J. E., Norris, P. T., & Reith, D. M. (2006). Use of centrally developed pharmacoeconomic assessments for local formulary decisions. American Journal of Health-System Pharmacy, 63(17), 1613-1618.

Grant, K., Al-Adhami, N., Tordoff, J., Livesey, J., Barbezat, G., & Reith, D. (2006). Continuation of proton pump inhibitors from hospital to community. Pharmacy World & Science, 28(4), 189-193.

Tordoff, J., Norris, P., Kennedy, J., & Reith, D. (2006). The influence of PHARMAC's National Hospital Pharmaceutical Strategy on quality use of medicines activities in New Zealand hospitals. New Zealand Medical Journal, 119(1239). Retrieved from http://journal.nzma.org.nz/journal/119-1239/2100/content.pdf

Balakrishnan, K., Grieve, J., Tordoff, J., Norris, P., & Reith, D. (2006). Pediatric licensing status and the availability of suitable formulations for new medical entities approved in the United States between 1998 and 2002. Journal of Clinical Pharmacology, 46(9), 1038-1043.

Didham, R., Dovey, S., & Reith, D. (2006). Characteristics of general practitioner consultations prior to suicide: A nested case-control study in New Zealand. New Zealand Medical Journal, 119(1247). Retrieved from http://journal.nzma.org.nz/journal/119-1247/2358/content.pdf

Kunac, D. L., Reith, D. M., Kennedy, J., Austin, N. C., & Williams, S. M. (2006). Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients. Quality & Safety in Health Care, 15, 196-201.

Tordoff, J., Norris, P., Kennedy, J., & Reith, D. (2005). Quality use of medicines activities in New Zealand hospitals from 2000 to 2002. New Zealand Medical Journal, 118(1208). Retrieved from http://journal.nzma.org.nz/journal/118-1208/1259/content.pdf

Lingvall, M., Reith, D., & Broadbent, R. (2005). The effect of sepsis upon gentamicin pharmacokinetics in neonates. British Journal of Clinical Pharmacology, 59(1), 54-61.

Tordoff, J. M., Norris, P. T., & Reith, D. M. (2005). Managing prices for hospital pharmaceuticals: A successful strategy for New Zealand? Value in Health, 8(3), 201-208.

Grieve, J., Tordoff, J., Reith, D., & Norris, P. (2005). Effect of the Pediatric Exclusivity Provision on children's access to medicines. British Journal of Clinical Pharmacology, 59(6), 730-735.

Reith, D., Fountain, J., & Tilyard, M. (2005). Opioid poisoning deaths in New Zealand (2001-2002). New Zealand Medical Journal, 118(1209). Retrieved from http://journal.nzma.org.nz/journal/118-1209/1293/content.pdf

Kunac, D. L., & Reith, D. M. (2005). Identification of priorities for medication safety in neonatal intensive care. Drug Safety, 28(3), 251-261.

Tordoff, J. M., Norris, P. T., Kennedy, J. M., & Reith, D. M. (2005). Influence of the National Hospital Pharmaceutical Strategy on the assessment of new medicines in New Zealand public hospitals. Journal of Pharmacy Practice & Research, 35(4), 271-275.

Fountain, J. S., Reith, D. M., & Watts, M. (2005). Comparison of CD-Rom and Internet access to clinical information. International Journal of Medical Informatics, 74(9), 769-777.

Chui, J., Tordoff, J., & Reith, D. (2005). Changes in availability of paediatric medicines in Australia between 1998 and 2002. British Journal of Clinical Pharmacology, 59(6), 736-742.

Carter, G., Reith, D. M., Whyte, I. M., & McPherson, M. (2005). Non-suicidal deaths following hospital-treated self-poisoning. Australian & New Zealand Journal of Psychiatry, 39, 101-107.

Didham, R. C., McConnell, D. W., Blair, H. J., & Reith, D. M. (2005). Suicide and self-harm following prescription of SSRIs and other antidepressants: Confounding by indication. British Journal of Clinical Pharmacology, 60(5), 519-525.

Didham, R. C., Reith, D. M., McConnell, D. W., & Harrison, K. S. (2005). Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Research & Treatment, 92, 163-167.

Carter, G., Reith, D. M., Whyte, I. M., & McPherson, M. (2005). Repeated self-poisoning: Increasing severity of self-harm as a predictor of subsequent suicide. British Journal of Psychiatry, 186, 253-257.

McEniery, J. A., Delbridge, R. G., & Reith, D. M. (2004). Infant pertussis deaths and the management of cardiovascular compromise. Journal of Paediatrics & Child Health, 40, 230-232.

Reith, D. M., Whyte, I., Carter, G., McPherson, M., & Carter, N. (2004). Risk factors for suicide and other deaths following hospital treated self-poisoning in Australia. Australian & New Zealand Journal of Psychiatry, 38(7), 520-525.

Watts, M., Fountain, J. S., Reith, D., & Schep, L. (2004). Compliance with Poisons Center referral advice and implications for toxicovigilance. Journal of Toxicology: Clinical Toxicology, 42(5), 603-610.

Chui, J., Tordoff, J., Kennedy, J., & Reith, D. (2004). Trends in accessibility to medicines for children in New Zealand: 1998-2002. British Journal of Clinical Pharmacology, 57(3), 322-327.

Tordoff, J. M., Norris, P., Kennedy, J. M., & Reith, D. M. (2004). Processes for the assessment and introduction of new medicines in New Zealand hospitals. Journal of Pharmacy Practice & Research, 34(4), 267-271.

Hwang, C., Foot, C., Eddie, G., Johnson, L., & Reith, D. M. (2003). The utility of the history and clinical signs of poisoning in childhood: A prospective study. Therapeutic Drug Monitoring, 25(5), 728-734.

Johansson, M., Hall, J., Reith, D. M., Jackson, P., & Tilyard, M. (2003). Trends in the use of inhaled corticosteroids for childhood asthma in New Zealand. European Journal of Clinical Pharmacology, 59, 483-487.

Reith, D. M., Burke, C., Appleton, D. B., Wallace, G., & Pelekanos, J. (2003). Tolerability of topiramate in children and adolescents. Journal of Paediatrics & Child Health, 39, 416-419.

Reith, D. M., Whyte, I., & Carter, G. (2003). Repetition risk for adolescent self-poisoning: A multiple event survival analysis. Australian & New Zealand Journal of Psychiatry, 37(2), 212-218.

Reith, D., Fountain, J., Tilyard, M., & McDowell, R. (2003). Antidepressant poisoning deaths in New Zealand for 2001. New Zealand Medical Journal, 116(1184). Retrieved from http://journal.nzma.org.nz/journal/116-1184/646/content.pdf

Watts, M., Fountain, J., Reith, D. M., & Herbison, G. P. (2003). Clinical utility of an electronic poisons information and clinical decision support tool. International Journal of Medical Informatics, 71, 3-8.

Westhuyen, J., Endre, Z. H., Reece, G., Reith, D. M., Saltissi, D., & Morgan, T. J. (2003). Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrology Dialysis Transplantation, 18(3), 543-551.

Rush, J. A., & Reith, D. M. (2003). Information sources accessed by parents following childhood poisoning. Paediatric Emergency Medicine, 15, 348-352.

Reith, D. M., Fountain, J., McDowell, R., & Tilyard, M. (2003). Comparison of the fatal toxicity index of zopiclone with benzodiazepines. Journal of Toxicology: Clinical Toxicology, 41(7), 975-980.

Reith, D. M., O'Regan, P., Bailey, C., & Acworth, J. (2003). Serious lead poisoning in childhood: Still a problem after a century. Journal of Paediatrics & Child Health, 39, 623-626.

Reith, D. M., Whyte, I., Carter, G., & McPherson, M. (2003). Adolescent self-poisoning: A cohort study of subsequent suicide and premature deaths. Crisis, 24(2), 79-84. doi: 10.1027//0227-5910.24.2.79

de la Porte, M., Reith, D. M., & Tilyard, M. (2002). Impact of safety alerts upon prescribing of cisapride to children in New Zealand. New Zealand Medical Journal, 115(1157), U24. Retrieved from www.nzma.org.nz/journal/115-1157/24

Reith, D. M., Hooper, W. D., Parke, J., & Charles, B. (2001). Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents and adults. Journal of Pharmacokinetics & Pharmacodynamics, 28(1), 79-92. doi: 10.1023/A:1011569703060

Baer, E., & Reith, D. M. (2001). Acetazolamide poisoning in a toddler. Journal of Paediatrics & Child Health, 37(4), 411-412.

Reith, D. M., Andrews, J., & McLaughlin, D. (2001). Valproic acid has temporal variability in urinary clearance of metabolites. Chronobiology International, 18(1), 123-129.

Reith, D. M., Pitt, W. R., & Hockey, R. (2001). Childhood poisoning in Queensland: An analysis of presentation and admission rates. Journal of Paediatrics & Child Health, 37(5), 446-450.

Whyte, I. M., Buckley, N. A., Reith, D. M., Goodhew, I., Seldom, M., & Dawson, A. H. (2000). Acetaminophen causes an increased INR by reducing functional factor VII. Therapeutic Drug Monitoring, 22(6), 742-748.

Reith, D. M., Appleton, D. B., Hooper, W. D., & Eadie, M. J. (2000). The effect of body size on the metabolic clearance of carbamazepine. Biopharmaceutics & Drug Disposition, 21, 103-111.

Healy, H., Reith, D., Morgan, C., Clague, D. A., & Westhuizen, J. (2000). Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure? Annals of Clinical & Laboratory Science, 30(3), 295-304.

Reith, D. M., Andrews, J., Parker-Scott, S. L., & Eadie, M. J. (2000). Urinary excretion of Valproate metabolites in children and adolescents. Biopharmaceutics & Drug Disposition, 21(8), 327-330.

Reith, D. M., & Cannell, G. (1999). A HPLC assay for carbamazepine phase I metabolites and their glucuronides in urine. Journal of Liquid Chromatography & Related Technologies, 22(12), 1805-1811.

Buckley, N. A., Dawson, A. H., Whyte, I. M., & Reith, D. M. (1999). Preformatted admission charts for poisoning admissions facilitate clinical assessment and research. Annals of Emergency Medicine, 34(4, Part 1), 476-482.

Reith, D., Monteleone, J. P. R., Ebelling, B., Holford, N. H. G., Carter, G., & Whyte, I. M. (1998). Features and toxicokinetics of Clozapine in overdose. Therapeutic Drug Monitoring, 20(1), 92-97.

^ Top of page

Journal - Research Other

Dovey, S. M., Leitch, S., Wallis, K. A., Eggleton, K. S., Cunningham, W. K., Williamson, M. I., … Tilyard, M. W., Reith, D. M., Samaranayaka, A., & Hall, J. E. (2017). Epidemiology of patient harms in New Zealand: Protocol of a general practice records review study. JMIR Research Protocols, 6(1), e10. doi: 10.2196/resprot.6696

Jayathissa, S., Dixon, P., Bruce, R., & Reith, D. (2017). Refining metformin prescribing in New Zealand. New Zealand Medical Journal, 130(1452), 49-53. Retrieved from https://www.nzma.org.nz/journal

Young, A., Tordoff, J., Dovey, S., Reith, D., Lloyd, H., Tilyard, M., & Smith, A. (2016). Using an electronic decision support tool to reduce inappropriate polypharmacy and optimize medicines: rationale and methods. JMIR Research Protocols, 5(2), e105. doi: 10.2196/resprot.5543

Ross, P. L., Milburn, J., Reith, D. M., Wiltshire, E., & Wheeler, B. J. (2015). Clinical review: Insulin pump-associated adverse events in adults and children. Acta Diabetologica, 52(6), 1017-1024. doi: 10.1007/s00592-015-0784-2

Lala, A. C., Broadbent, R. S., Medlicott, N. J., Sherwin, C. M. T., & Reith, D. M. (2015). Illustrative neonatal cases regarding drug delivery issues. Journal of Paediatrics & Child Health, 51, 478-481. doi: 10.1111/jpc.12764

Wheeler, B. J., Taylor, B. J., Simonsen, K., & Reith, D. M. (2015). Acebutolol and immediate release melatonin in treatment of Smith-Magenis syndrome. Journal of Medical Cases, 6(4), 176-178. doi: 10.14740/jmc2102w

Fountain, J. S., & Reith, D. M. (2014). Dangers of "EDTA". New Zealand Medical Journal, 127(1398). Retrieved from http://www.nzma.org.nz/journal

Ragupathy, R., Aaltonen, K., Tordoff, J., Norris, P., & Reith, D. (2013). The authors' reply to Wonder and Milne: 'Comparing subsidized access to medicines across payer systems'. Pharmacoeconomics, 31(2), 175-176. doi: 10.1007/s40273-012-0014-5

More publications...